RJMPDRN REC is a vegan-certified recombinant PDRN produced through a patented biological synthesis platform using engineered ...

Preclinical evaluation in mice assessed the potential of the Nanobiotix Nanoprimer to overcome common barriers faced by lipid nanoparticle(“LNP”)-delivered therapies related to rapid liver ...

Explore the contrasting acceptance of gene therapy and genetic crop modification, highlighting societal attitudes and ...

Nanobiotix ( (NBTX)) has issued an update. On April 20, 2026, Nanobiotix reported new preclinical data for its Nanoprimer platform, presented at the American Association for Cancer Research annual ...

Synthetic biologists were tantalized by the idea of making mirror images of microbes. Then things got complicated.

Now is the time to choose between recklessness and prudence On July 16, 1945, when the world’s first nuclear explosion shook the plains of New Mexico, J. Robert Oppenheimer, who led the project, ...

Canada's AuX Labs has raised $4M in funding to scale up production of its precision-fermented dairy protein and bring ...

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today ...

Brii Biosciences Limited  ("Brii Bio," "Brii," or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet ...

This paper provides a valuable observation that imiquimod, a compound often used to induce a psoriasis-like skin inflammation in mice, has a TLR7-independent effect acting through the unfolded protein ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...